B

Black Diamond Therapeutics
D

BDTX

6.07000
USD
-0.02
(-0.33%)
Market Closed
Volume
22,511
EPS
0
Div Yield
0
P/E
-2
Market Cap
168,949,636
News

Title: Black Diamond Therapeutics

Sector: Healthcare
Industry: Biotechnology
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.